{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:09:37Z","timestamp":1761523777907},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Globally, cervical cancer is the fourth most common cancer in women. Here, we report a case of cutaneous lymphangitis carcinomatosa arising from cervical cancer, an extremely rare and treatment-resistant condition.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 64-year-old Japanese woman presented with genital bleeding. She was diagnosed as having stage IB1 squamous cell cervical cancer and subsequently treated with radiotherapy. Approximately 2\u2009years after the curative radiotherapy, she developed itching, skin rash, and small nodules on her left femoral and pubic area. Slight <jats:sup>18<\/jats:sup>F-fluorodeoxyglucose uptake was detected at her left femoral skin on positron emission tomography with computed tomography. A histopathological examination was performed on a biopsy sample from an erythematous macule on her left femoral skin and vulva. Consequently, she was diagnosed as having cutaneous lymphangitis carcinomatosa arising from cervical cancer. Paclitaxel (135\u2009mg\/m<jats:sup>2<\/jats:sup>), cisplatin (50\u2009mg\/m<jats:sup>2<\/jats:sup>), and bevacizumab (15\u2009mg\/kg) combination therapy was administered every 21\u2009days. Both itching and rash improved after three treatment cycles. After the completion of six\u2009cycles, skin erythema in the femoral and vulval area disappeared completely. Our patient experienced a 25-month symptom-free interval after the last chemotherapy session.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our findings suggest that combination chemotherapy plus bevacizumab is an effective therapeutic option in patients with cutaneous lymphangitis carcinomatosa arising from cervical cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13256-019-2262-x","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T09:04:41Z","timestamp":1573117481000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Successful management of cutaneous lymphangitis carcinomatosa arising from cervical cancer with paclitaxel-cisplatin and bevacizumab combination therapy: a case report and review of the literature"],"prefix":"10.1186","volume":"13","author":[{"given":"Fumihiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Seino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotsugu","family":"Sakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"2262_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1097\/IGC.0000000000001000","volume":"27","author":"VM Rosen","year":"2017","unstructured":"Rosen VM, Guerra I, McCormack M, Nogueira-Rodrigues A, Sasse A, Munk VC, Shang A. Systematic review and network meta-analysis of bevacizumab plus first-line topotecan-paclitaxel or cisplatin-paclitaxel versus non-bevacizumab-containing therapies in persistent, recurrent, or metastatic cervical cancer. Int J Gynecol Cancer. 2017;27:1237\u201346.","journal-title":"Int J Gynecol Cancer"},{"key":"2262_CR2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/ygyno.2009","volume":"114","author":"L Elit","year":"2009","unstructured":"Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M, Gynecology Cancer Disease Site Group. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol. 2009;114:528\u201335. \nhttps:\/\/doi.org\/10.1016\/ygyno.2009\n\n.","journal-title":"Gynecol Oncol"},{"key":"2262_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1148\/88.5.961","volume":"88","author":"V Cartson","year":"1967","unstructured":"Cartson V, Delclos L, Fletcher GH. Distant metastases in squamous-cell carcinoma of the uterine cervix. Radiology. 1967;88:961\u20136. \nhttps:\/\/doi.org\/10.1148\/88.5.961\n\n.","journal-title":"Radiology"},{"key":"2262_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-008-0432-0","volume":"135","author":"D Nashan","year":"2009","unstructured":"Nashan D, Muller ML, Braun-Falco M, Reichenberger S, Szeimies RM, Bruckner-Tuderman L. Cutaneous metastases of visceral tumours: a review. J Cancer Res Clin Oncol. 2009;135:1\u201314.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2262_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0090-8258(86)90025-9","volume":"24","author":"JH Malfetano","year":"1986","unstructured":"Malfetano JH. Skin metastasis from cervical carcinoma a fatal event. Gynecol Oncol. 1986;24:177\u201382.","journal-title":"Gynecol Oncol"},{"key":"2262_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1006\/gyno.1993.1061","volume":"48","author":"M Imachi","year":"1993","unstructured":"Imachi M, Tsukamoto N, Kinoshita S, Nakano H. Skin metastasis from carcinoma of the uterine cervix. Gynecol Oncol. 1993;48:349\u201354.","journal-title":"Gynecol Oncol"},{"key":"2262_CR7","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.jaad.2006.03.028","volume":"56","author":"HI Yang","year":"2007","unstructured":"Yang HI, Lee MC, Kuo TT, Hong HS. Cellulitis-like cutaneous metastasis of uterine cervical carcinoma. J Am Acad Dermatol. 2007;56:S26\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"2262_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1006\/gyno.1999.5704","volume":"76","author":"S Pertzborn","year":"2000","unstructured":"Pertzborn S, Buekers TE, Sood AK. Hematogenous skin metastases from cervical cancer at primary presentation. Gynecol Oncol. 2000;76:416\u20137.","journal-title":"Gynecol Oncol"},{"key":"2262_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1470-2045(15)70004-5","volume":"16","author":"RT Penson","year":"2015","unstructured":"Penson RT, Huang HQ, Wenzel LB, Monk BJ, Stockman S, Long HJ 3rd, et al. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). Lancet Oncol. 2015;16:301\u201311. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(15)70004-5\n\n.","journal-title":"Lancet Oncol"},{"key":"2262_CR10","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","volume":"28","author":"T Shin","year":"2006","unstructured":"Shin T, Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther. 2006;28:1779\u2013802. \nhttps:\/\/doi.org\/10.1016\/j.clinthera.2006.11.015\n\n.","journal-title":"Clin Ther"},{"key":"2262_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192\u20138. \nhttps:\/\/doi.org\/10.1038\/84643\n\n.","journal-title":"Nat Med"},{"key":"2262_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J. 2001;20:672\u201382. \nhttps:\/\/doi.org\/10.1093\/emboj\/20.4.672\n\n.","journal-title":"EMBO J"},{"key":"2262_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2559.2005.02098.x","volume":"46","author":"M Fukunaga","year":"2005","unstructured":"Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology. 2005;46:396\u2013402.","journal-title":"Histopathology"},{"key":"2262_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0190-9622(95)90231-7","volume":"33","author":"RA Schwartz","year":"1995","unstructured":"Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol. 1995;33:161\u201384.","journal-title":"J Am Acad Dermatol"},{"key":"2262_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1701-2163(16)34501-7","volume":"32","author":"A Agrawal","year":"2010","unstructured":"Agrawal A, Yau A, Magliocco A, Chu P. Cutaneous metastatic disease in cervical cancer: a case report. J Obstet Gynaecol Can. 2010;32:467\u201372.","journal-title":"J Obstet Gynaecol Can"},{"key":"2262_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00404-008-0617-4","volume":"278","author":"N Behtash","year":"2008","unstructured":"Behtash N, Mehrdad N, Shamshirsaz A, Hashemi R, Amouzegar Hashemi F. Umblical metastasis in cervical cancer. Arch Gynecol Obstet. 2008;278:489\u201391.","journal-title":"Arch Gynecol Obstet"},{"key":"2262_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10147-015-0806-7","volume":"20","author":"Y Ebina","year":"2015","unstructured":"Ebina Y, Yaegashi N, Katabuchi H, Nagase S, Udagawa Y, Hachisuga T, et al. Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer. Int J Clin Oncol. 2015;20:240\u20138. \nhttps:\/\/doi.org\/10.1007\/s10147-015-0806-7\n\n.","journal-title":"Int J Clin Oncol"},{"key":"2262_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMoa1309748","volume":"370","author":"KS Tewari","year":"2014","unstructured":"Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734\u201343.","journal-title":"N Engl J Med"},{"key":"2262_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4274\/tjod.40225","volume":"14","author":"H\u00c7 \u00d6zcan","year":"2017","unstructured":"\u00d6zcan H\u00c7, Mustafa A, Bozda\u011f Z, Sucu S, U\u011fur MG, Balat \u00d6. Early vulvar and umbilical incisional scar recurrence of cervical squamous cell carcinoma: earlier than usually expected. Turk J Obstet Gynecol. 2017;14:141\u20134. \nhttps:\/\/doi.org\/10.4274\/tjod.40225\n\n.","journal-title":"Turk J Obstet Gynecol"},{"key":"2262_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13256-016-1042-0","volume":"10","author":"M Benoulaid","year":"2016","unstructured":"Benoulaid M, Elkacemi H, Bourhafour I, Khalil J, Elmajjaoui S, Khannoussi B, et al. Skin metastases of cervical cancer: two case reports and review of the literature. J Med Case Rep. 2016;10:265. \nhttps:\/\/doi.org\/10.1186\/s13256-016-1042-0\n\n.","journal-title":"J Med Case Rep"},{"key":"2262_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5152\/jtgga.2013.62444","volume":"14","author":"B Basu","year":"2013","unstructured":"Basu B, Mukherjee S. Cutaneous metastasis in cancer of the uterine cervix: a case report and review of the literature. J Turk Ger Gynecol Assoc. 2013;14:174\u20137. \nhttps:\/\/doi.org\/10.5152\/jtgga.2013.62444\n\n. eCollection 2013","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"2262_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/gyno.2001.6559","volume":"85","author":"N Behtash","year":"2002","unstructured":"Behtash N, Ghaemmaghami F, Yarandi E, Ardalan FA, Khanafshar N. Cutaneous metastasis from carcinoma of the cervix at the drain site. Gynecol Oncol. 2002;85:209\u201311. \nhttps:\/\/doi.org\/10.1006\/gyno.2001.6559\n\n.","journal-title":"Gynecol Oncol"},{"key":"2262_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/gyno.2002.6808","volume":"87","author":"I Palaia","year":"2002","unstructured":"Palaia I, Angioli R, Cutillo G, Manci N, Panici PB. Skin relapse from cervical cancer. Gynecol Oncol. 2002;87:155\u20136.","journal-title":"Gynecol Oncol"},{"key":"2262_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1067\/mid2001.1123489","volume":"45","author":"MH Kagen","year":"2001","unstructured":"Kagen MH, Ruhl KK, Aghajanian C, Myskowski PI. Squamous cell carcinoma of the cervix metastatic to the skin. J Am Acad Drmatol. 2001;45:133\u20135. \nhttps:\/\/doi.org\/10.1067\/mid2001.1123489\n\n.","journal-title":"J Am Acad Drmatol"},{"key":"2262_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1001\/archderm.1982.01650130044018","volume":"118","author":"CR Freeman","year":"1982","unstructured":"Freeman CR, Rozenfeld M, Schopflocher P. Cutaneous metastases from carcinoma of the cervix. Arch Dermatol. 1982;118:40\u20131.","journal-title":"Arch Dermatol"},{"key":"2262_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1097\/ICO.0000000000000899","volume":"35","author":"JC Tan","year":"2016","unstructured":"Tan JC, Mann S, Coronea MT. Successful treatment of conjunctival lymphangiectasia with subconjunctival injection of bevacizumab. Cornea. 2016;35:1375\u20137. \nhttps:\/\/doi.org\/10.1097\/ICO.0000000000000899\n\n.","journal-title":"Cornea"},{"key":"2262_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5732\/cjc.012.10319","volume":"32","author":"SA Stacker","year":"2013","unstructured":"Stacker SA, Achen MG. The VEGF signaling pathway in cancer: the road ahead. Chin J Cancer. 2013;32:297\u2013302. \nhttps:\/\/doi.org\/10.5732\/cjc.012.10319\n\n.","journal-title":"Chin J Cancer"},{"key":"2262_CR28","first-page":"2249","volume":"39","author":"H Min Kim","year":"2012","unstructured":"Min Kim H, Hasegawa J, Hirota M, Matsunami N, Mikata S, Shimizu J, et al. A case of sigmoid colon cancer with Virchow's lymph node metastasis successfully treated with chemotherapy. Gan To Kagaku Ryoho. 2012;39:2249\u201351.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2262_CR29","first-page":"535","volume":"37","author":"S Sogabe","year":"2010","unstructured":"Sogabe S, Yuki S, Takagi T, Miyazaki T, Takano H, Kuwamoto Y, et al. A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs. Gan To Kagaku Ryoho. 2010;37:535\u20138.","journal-title":"Gan To Kagaku Ryoho"},{"key":"2262_CR30","first-page":"617","volume":"43","author":"E Suzuki","year":"2016","unstructured":"Suzuki E, Tanahashi M, Yukiue H, Yohii N, Shitara M, Fujino T, Niwa H. A patient with lung adenocarcinoma, lymphangitis carcinomatosa, and multiple bone metastases who achieved long-term survival after successful treatment with carboplatin, paclitaxel, and bevacizumab. Gan To Kagaku Ryoho. 2016;43:617\u201320.","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2262-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:24:49Z","timestamp":1604622289000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2262-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2262"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2262-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"9 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Author, S Nagase, received lecture fees from Chugai Pharmaceutical Co., Ltd. and AstraZeneca. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"328"}}